A budesonide slurry for eosinophilic esophagitis (EOE) is made by mixing liquid budesonide, typically from nebulizer ampules called respules, with a thickening agent so the medication coats the esophagus on the way down. The recipe itself is straightforward, but the details matter: which thickening agent you use, how you take it, and what you avoid afterward all affect how well the drug works. Because EOE involves chronic inflammation of the esophagus driven by immune cells called eosinophils, the goal is to get a steroid to sit on the esophageal lining long enough to calm things down, and the slurry format does that better than swallowing a nebulized mist or spraying an inhaler into your mouth.
Why a Slurry Instead of an Inhaler or Nebulizer
The logic behind the slurry is simple: thicker liquids cling to the esophagus longer, and longer contact time means more eosinophil suppression. A study using scintigraphy (imaging that tracks where a swallowed substance goes) found that a viscous budesonide preparation stayed in contact with the esophageal lining significantly longer than a nebulized version, and that increased contact time correlated directly with lower eosinophil counts after treatment.1PubMed Central. Viscous topical is more effective than nebulized steroid therapy for patients with eosinophilic esophagitis That correlation is the whole rationale: the drug needs to touch the tissue to treat it, and a thin liquid or aerosolized mist passes through too quickly.
Three main forms of swallowed topical steroids exist for EOE: the oral viscous budesonide slurry (what this article covers), orodispersible budesonide tablets that dissolve on the tongue, and fluticasone sprayed from an inhaler into the mouth and swallowed.2PubMed Central. Swallowed topical steroid therapy for eosinophilic oesophagitis in children: practical, evidence-based guidance by the BSPGHAN Eosinophilic Oesophagitis Working Group The slurry is especially common for younger children and for anyone whose doctor prefers the flexibility of adjusting the dose by changing the number of respules used. In a head-to-head randomized trial, viscous budesonide and swallowed fluticasone from a metered-dose inhaler produced similar improvements in eosinophil counts, dysphagia, and endoscopic findings, with roughly two-thirds of patients in each group achieving a histologic response.3PubMed Central. Efficacy of Budesonide vs Fluticasone for Initial Treatment of Eosinophilic Esophagitis in a Randomized Controlled Trial A meta-analysis confirmed no significant difference between the two drugs for histologic response.4PubMed Central. Comparison of viscous budesonide and fluticasone in the treatment of patients with eosinophilic esophagitis: a systematic review and meta-analysis So the choice often comes down to cost, availability, and which format you or your child can actually tolerate twice a day for months.
The Basic Recipe
The standard homemade slurry uses budesonide respules, the small plastic ampules of liquid budesonide sold for use in nebulizers. A typical adult dose is 1 mg twice daily, though some protocols go higher. You crack open the respule, squeeze the liquid into a small cup, and stir in your thickening agent until the mixture reaches a syrupy consistency. The total volume is small, usually just a few tablespoons, so that you can swallow it in a few slow sips.
Your doctor will specify the dose in milligrams and how many times per day. Respules commonly come in 0.25 mg and 0.5 mg strengths, so you may need to combine two or more ampules per dose. The mixing itself takes about a minute: add the thickening agent, stir thoroughly, and you are ready.
Choosing a Thickening Agent
This is where patients and doctors have the most options, and where some genuine differences show up. The most widely used mixing agent in the United States has been sucralose, sold as Splenda. The traditional recipe calls for roughly five to ten packets of Splenda stirred into the budesonide until it forms a slurry with a honey-like thickness. The sucralose adds sweetness (which helps with taste) and enough viscosity to slow esophageal transit.
Not everyone wants to swallow that much artificial sweetener twice a day, especially parents dosing young children.5Pediatrics. Comparison of 2 Delivery Vehicles for Viscous Budesonide to Treat Eosinophilic Esophagitis in Children A study comparing sucralose-based slurry to one made with Neocate Nutra, a hypoallergenic thickening powder designed for infants, found that both worked equally well at reducing eosinophil counts and achieving histologic remission.6PubMed. Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children Families who preferred to avoid artificial sweeteners had a clinically equivalent alternative.
Another option that has been studied is xanthan gum, a common food thickener. In a controlled comparison measuring esophageal clearance times, xanthan gum kept the medication in contact with the esophagus significantly longer than sucralose did. Honey, by contrast, offered no meaningful improvement in contact time over sucralose.7PubMed. A Randomized Controlled Comparison of Esophageal Clearance Times of Oral Budesonide Preparations That makes xanthan gum an appealing choice from a pharmacologic standpoint, though its neutral flavor and slightly gummy texture are not as palatable as Splenda’s sweetness. Some patients mix a small amount of xanthan gum with a flavored syrup to improve taste.
A pediatric study using a pharmacy-prepared viscous budesonide formulation found that about two-thirds of the children achieved histologic remission at eight weeks, and no side effects, including esophageal candidiasis, were observed during the study period.8PubMed Central. A New Viscous Budesonide Formulation for the Treatment of Eosinophilic Esophagitis in Children: A Preliminary Experience and Review of the Literature When comparing different vehicle types more broadly, one retrospective analysis found an overall histologic remission rate of about 53% with oral viscous budesonide, with no significant difference among the various vehicles used.9PubMed. Comparison of budesonide vehicles in inducing histologic remission in pediatric eosinophilic esophagitis The takeaway: the vehicle matters less than getting adequate contact time and using the right dose. Pick whichever thickener you can tolerate consistently.
How to Take It
The way you swallow the slurry is almost as important as what is in it. Standard guidance is to sip the mixture slowly, letting each sip coat the back of the throat and slide down the esophagus. Do not chase it with water. Do not eat or drink for at least 30 minutes afterward. Some clinicians recommend waiting a full hour. The point is to avoid washing the steroid off the esophageal surface before it has had time to absorb.
Most protocols call for twice-daily dosing, once in the morning and once at bedtime. The bedtime dose is especially important because you naturally swallow less while sleeping, so the medication sits on the tissue longer. If you are preparing the slurry for a child, the dose and frequency will be adjusted by their gastroenterologist. For children too young to sip cooperatively, some families use an oral syringe to deliver small amounts into the cheek.
One practical tip: do not brush your teeth or rinse your mouth immediately after taking the bedtime dose. While oral candidiasis (thrush) is a known side effect of topical steroids in the mouth, and rinsing the mouth might seem like it would help prevent that, the priority with EOE treatment is keeping the medication on the esophagus. Your doctor can advise you on balancing these concerns. Some clinicians suggest rinsing only your mouth (spitting, not swallowing) if candidiasis becomes an issue, while still avoiding food and water.
Side Effects to Watch For
Budesonide is a topical steroid, and the slurry delivers it directly to the esophageal and oral mucosa. The most common side effect is oral or esophageal candidiasis, a fungal infection. In one cohort study, about 15% of patients on budesonide developed candidiasis during treatment, mostly during the higher-dose induction phase. Oral cases presented as a cotton-like sensation and white patches on the tongue, palate, or inner cheeks. These resolved with a topical antifungal rinse over about 10 days. Esophageal candidiasis was less common and typically asymptomatic, discovered only during follow-up endoscopy.10PubMed Central. Risk factors for oral and esophageal candidiasis during budesonide treatment in eosinophilic esophagitis patients
Longer-term data are reassuring. In a study tracking patients on topical corticosteroids for a median of 6.5 years, esophageal candidiasis occurred in only about 4% of patients at their final endoscopy, and serious complications like adrenal insufficiency or bone thinning were each seen in roughly 1%.11PubMed Central. Topical steroids are effective and safe in patients with eosinophilic esophagitis over a median of 6.5 years of chronic use That said, the systemic absorption question is not fully settled, particularly for children. A pilot study of children treated with oral viscous budesonide for at least three months found that a substantial proportion had suboptimal cortisol responses on stimulation testing, suggesting some degree of adrenal suppression, without a clear link to dose or duration.12Journal of Pediatric Gastroenterology and Nutrition. Adrenal Suppression in Children Treated With Oral Viscous Budesonide for Eosinophilic Esophagitis: A Pilot Study This was a small study and not conclusive, but it is why many pediatric gastroenterologists periodically monitor adrenal function in children on long-term slurry therapy.
Compounded Slurry Versus Homemade
You will hear the terms “compounded budesonide” and “homemade slurry” used somewhat interchangeably, but they are different things. A compounded preparation is made by a pharmacy to a doctor’s prescription, using pharmaceutical-grade ingredients and a standardized formulation. A homemade slurry is what you make in your kitchen with store-bought respules and a thickening agent.
Both approaches deliver the same active ingredient. The advantage of compounding is consistency: the pharmacy controls viscosity, concentration, and flavoring. The disadvantage is availability and insurance. A survey of pharmacies in Michigan found that only about 29% offered compounded budesonide suspension for EOE, and the formulations, dosing, and patient instructions varied from one pharmacy to the next.13PubMed Central. Variability in Practices of Compounding Budesonide for Eosinophilic Esophagitis That variability is a real concern. If you go the compounding route, it is worth confirming with the pharmacist exactly what formulation they use and comparing it with what your gastroenterologist prescribed.
Cost differences can be dramatic. One analysis found that six weeks of budesonide respules at 1 mg twice daily ran about $1,600, while a compounded budesonide suspension at a higher dose of 3 mg twice daily cost only $141 for the same period. However, insurance companies are more likely to cover commercially available respules than compounded formulations.14PubMed Central. Compounded Oral Viscous Budesonide is Effective and Provides a Durable Response in Eosinophilic Esophagitis This creates a frustrating paradox: the cheaper product may cost you more out of pocket if your plan does not cover compounding. Ask your pharmacy and insurance provider before assuming which route is more affordable for you.
How Well Does the Slurry Work
Across studies, oral viscous budesonide reduces esophageal eosinophil counts significantly. In one cohort, the median peak eosinophil count dropped from 58 to 15 per high-power field after initial treatment, and about half the patients hit the standard threshold for histologic response. Endoscopic features like rings, furrows, and white plaques also improved substantially.14PubMed Central. Compounded Oral Viscous Budesonide is Effective and Provides a Durable Response in Eosinophilic Esophagitis These improvements translate to real symptom relief: less food sticking, less chest pain, fewer food impactions.
But “works” does not mean “cures.” EOE is a chronic condition, and when you stop the medication, inflammation tends to return. That brings up the question of maintenance therapy.
Staying on It Long-Term
Most gastroenterologists now treat EOE as a chronic disease requiring ongoing management rather than a short course of therapy. Low-dose budesonide maintained over the long term is more effective than placebo at keeping eosinophil counts down and preserving remission, and long-term use has been well tolerated without inducing esophageal tissue thinning.15Clinical Gastroenterology and Hepatology. Long-Term Budesonide Maintenance Treatment Is Partially Effective for Patients With Eosinophilic Esophagitis
The catch is dose reduction. One study found that among patients who initially responded to topical steroids, about 61% lost that response over time. The patients who relapsed were on significantly lower maintenance doses than those who sustained remission. Specifically, patients kept on more than 1,000 micrograms of budesonide daily had much lower odds of losing their response compared to those whose dose was cut below that level. By about 18 months on reduced-dose maintenance, half the patients had already relapsed.16PubMed Central. Diminishing Effectiveness of Long-Term Maintenance Topical Steroid Therapy in PPI Non-Responsive Eosinophilic Esophagitis The practical lesson is that the dose you taper down to matters. If your doctor reduces your maintenance dose and symptoms return, a dose increase rather than a switch to another therapy is often the first step.
Sticking With It Every Day
Knowing how to make the slurry is one thing. Taking it consistently for months or years is another. In a survey of EOE patients and caregivers, more than half of adolescents’ caregivers reported that bad taste was the top reason their child skipped doses. Among adults, the most common barrier was difficulty taking the medication at a specific time, followed by feeling overwhelmed and by the perception that symptoms were not bothersome enough to justify daily treatment.17PubMed Central. Satisfaction With and Adherence to Off-Label Corticosteroids in Adolescents and Adults With Eosinophilic Esophagitis: Results of a Web-Based Survey in the United States
That last point deserves emphasis. EOE can feel manageable between flares, especially if you have learned to chew carefully or avoid trigger foods. But the inflammation continues even when you are not actively symptomatic, and untreated EOE can lead to esophageal narrowing and strictures over time. Symptom improvement without histologic improvement is not the same as remission. If you are tempted to stop because you feel fine, talk to your gastroenterologist first, ideally with a follow-up endoscopy to see what the tissue actually looks like.
For taste issues, experimenting with different vehicles can help. Some patients find that adding a small amount of flavoring (a few drops of vanilla extract or a sugar-free syrup) makes the slurry more tolerable without meaningfully changing its viscosity. Children who refuse the Splenda version may accept a Neocate Nutra version or a pharmacy-compounded preparation with added flavoring.
Combining the Slurry With Dietary Management
Many EOE patients use both topical steroids and an elimination diet, removing foods known to trigger eosinophilic inflammation (commonly milk, wheat, eggs, soy, nuts, and seafood). Research continues to explore the optimal way to combine these strategies.18PubMed. Medical and dietary management of eosinophilic esophagitis In one subgroup analysis, patients who used compounded budesonide alongside a food elimination diet had eosinophil counts comparable to those using budesonide alone, suggesting the combination is reasonable but does not necessarily produce a synergistic effect.14PubMed Central. Compounded Oral Viscous Budesonide is Effective and Provides a Durable Response in Eosinophilic Esophagitis
That does not mean diet is unhelpful. For some patients, identifying and eliminating a trigger food can reduce or even eliminate the need for medication. Others find that diet alone does not bring eosinophil counts below the treatment threshold. The decision to use the slurry, diet, or both depends on your specific triggers, how well you respond to each approach, and what you can sustain practically. Many gastroenterologists start with the slurry to get inflammation under control quickly, then layer in dietary changes to see if the medication can eventually be reduced.
What the Thickening Agent Should Not Contain
If you have EOE, you already know that food allergens drive the disease. It would be counterproductive to mix your anti-inflammatory medication with a substance that triggers your esophageal inflammation. Most standard thickening agents, like sucralose and xanthan gum, are not common allergens. But if you are using a specialty product like a nutritional powder, check the ingredients for milk protein, soy, or wheat derivatives. Neocate Nutra, for instance, was specifically designed to be hypoallergenic, which is one reason it was studied as a vehicle for budesonide in pediatric EOE patients.6PubMed. Comparison of 2 delivery vehicles for viscous budesonide to treat eosinophilic esophagitis in children
Honey is sometimes suggested as a natural thickener, but beyond its inferior esophageal contact time compared to xanthan gum, it should never be given to children under one year old due to the risk of botulism.7PubMed. A Randomized Controlled Comparison of Esophageal Clearance Times of Oral Budesonide Preparations For older children and adults, honey is safe but just does not perform as well in keeping the medication where it needs to be.
If you are sourcing your own ingredients, keep things simple. The budesonide does the therapeutic work. The vehicle’s only jobs are to slow transit, taste acceptable enough that you actually take it, and avoid introducing new allergens. Any food-grade thickener that accomplishes those three goals and that your doctor approves is a reasonable choice.